Florida, New York, United States Related Funds
| Fund Name | Location |
| AshHill Biomedical | Cincinnati, Ohio, United States |
| Beijing Ronghui Tongda Touzi Quanli Youxian Gongsi | Beijing, China, Haidian |
| Careismatic Brands | California, Chatsworth, United States |
| Clayton, Dubilier & Rice | New York, New York, United States |
| Draper | Cambridge, Massachusetts, United States |
| EXPERT DOJO | California, Santa Monica, United States |
| Lorient Capital | Birmingham, Michigan, United States |
| Macromill | Chiba Prefecture, Japan, Tateyama |
| Madison Capital Funding | Chicago, Illinois, United States |
| MB Venture Partners | Memphis, Tennessee, United States |
| Netmarble | Seoul, Seoul-t'ukpyolsi, South Korea |
| Next News Ventures | New York, New York, United States |
| NREP | - |
| Oy Hammaren & Co Ab | - |
| Proxima Media | California, Los Angeles, United States |
| Sanderling Ventures | California, San Mateo, United States |
| Shinkin Capital | Japan, Tokyo |
| Somerset Capital | Colorado, Denver, United States |
| The Three Sisters Institutional Office | - |
| Xiamen Torch Group Co | China, Fujian, Xiamen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Kate Therapeutics | $51M | 08 Jun 2023 | San Diego, California, United States | ||
Myosin Therapeutics | 14 Mar 2023 | Jupiter, Florida, United States | |||
StrideBio | $81M | 16 Mar 2021 | Durham, North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Kate Therapeutics | $51M | 08 Jun 2023 | San Diego, California, United States | ||
Myosin Therapeutics | 14 Mar 2023 | Jupiter, Florida, United States | |||
StrideBio | $81M | 16 Mar 2021 | Durham, North Carolina, United States |
